WeVote
Log In

Bill

Bill

S 4446

PRESS Act

119th Congress Introduced by Mike Crapo and 5 co-sponsors

The bill tightens controls on importing pill press machines to curb counterfeit drug production and strengthen penalties, screenings, and enforcement.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 4446

Summary of Bill: S. 4446 (119th Congress)

Title

A bill to amend the Controlled Substances Act to prevent the importation of illicit pill press machines with the intent to counterfeit substances, and for other purposes.

Purpose and intent

  • The primary aim is to address the illicit import and distribution of pill press machines that could be used to counterfeit controlled substances.
  • By tightening controls around importation and related activities, the bill seeks to reduce the availability of counterfeit pills on the illicit market and disrupt operations that facilitate drug trafficking and public health risks.

Key provisions (expected statutory changes)

Note: The summary reflects the bill’s stated broad objectives based on its title and typical mechanisms for this policy area. The actual text may specify details; the following highlights are representative of common elements in similar legislation:

  • Modification of the Controlled Substances Act (CSA):
    • Add or expand provisions to regulate, prohibit, or increase penalties for importing pill press machines and associated tooling intended for producing counterfeit dosage forms of controlled substances.
    • Create or enhance criminal penalties (fines, imprisonment terms) for individuals or entities involved in importing, distributing, or acquiring illicit pill presses with knowledge or intent to counterfeit substances.
  • Importation and Commerce Controls:
    • Strengthen border or customs screening criteria for pill presses and related equipment.
    • Require licenses, reporting, or prior notification for importers of pill press equipment.
    • Expand permissible seizure and forfeiture authorities for machines and related materials linked to counterfeit drug production.
  • Intent and Knowledge Standards:
    • Establish or reinforce mens rea requirements (e.g., intent to counterfeit, knowledge of illicit use) to impose penalties on offenders.
  • Definitions and Scope:
    • Clarify what qualifies as a “pill press machine” and related components (dies, molds, etc.) and the types of controlled substances targeted.
    • Specify the jurisdictional reach of the act’s provisions for importation and distribution activities.
  • Regulatory and Enforcement Provisions:
    • Authorize or direct relevant agencies (e.g., Department of Justice, Drug Enforcement Administration, Department of Homeland Security) to enforce the new prohibitions.
    • Provide funding or authority for investigative and prosecutorial efforts related to illicit pill press importation.

Who and what is affected

  • Individuals and entities involved in importing pill press machines and related equipment intended for counterfeit production of controlled substances.
  • Possibly importing brokers, distributors, manufacturers, and potentially arms-length intermediaries who knowingly facilitate such imports.
  • Law enforcement, prosecutors, and regulatory agencies responsible for enforcement, seizures, and penalties.
  • Public health and consumer safety interests by reducing the risk of counterfeit drugs entering the market.

Procedural and timeline aspects

  • Introduced in the Senate: April 30, 2026.
  • Referral: Referred to the Senate Committee on the Judiciary on April 30, 2026.
  • Co-sponsor: Ashley Moody (names a sponsored or co-sponsoring member).
  • Next steps in legislative process: If advanced, the bill would move through committee markup, potential floor debates, amendments, and votes in the Senate. If passed, it would proceed to the House (or vice versa, depending on companion bills) and then to a conference committee if there are differences between versions.

Practical impact and considerations

  • The bill aims to deter counterfeit substance production by targeting the production and import chain of pill-press equipment.
  • Enforcement would likely involve enhanced border screening, criminal penalties, and potential asset forfeiture.
  • Stakeholders may include importers of precision machinery, pharmaceutical distributors, drug policy advocates, and public health officials focused on reducing counterfeit drug risks.

If you’d like, I can tailor this summary to emphasize potential political, enforcement, or public health implications, or compare it to existing statutes and similar prior bills.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.